Evidence map›Paper›PMID 17976649›Full record

ArticleJournal of molecular biology2007

Conformational instability of the cholera toxin A1 polypeptide.

Abhay H Pande, Patricia Scaglione, Michael Taylor, Kathleen N Nemec, Summer Tuthill, David Moe, Randall K Holmes, Suren A Tatulian, Ken Teter

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Domperidone InhibitsToxins · 2023
    Article
  3. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Proline Isomerization as a Key Determinant for Hsp90-Toxin Interactions.Frontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Abhay H PandeDepartment of Molecular Biology and Microbiology, University of Central Florida, Orlando, FL 32826, USA.
Patricia Scaglione
Michael Taylor
Kathleen N Nemec
Summer Tuthill
David Moe
Randall K Holmes
Suren A Tatulian
Ken Teter
University of Central Florida · USUniversity of Colorado Denver · US

Funding

GENETIC ANALYSIS OF CHOLERA TOXIN STRUCTURE AND FUNCTIONR01AI031940 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, RANDALL K · 1992 to 2011
$5.9M
Toxin Thermal Instability and Its Role in Host-Toxin InteractionsR01AI073783 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI TETER, KENNETH R · 2007 to 2011
$1.8M
Study of Cholera Toxin Entry into the Eukaryotic CytosolK22AI054568 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI TETER, KENNETH R · 2004 to 2005
$265k
ELUCIDATION OF THE CHOLERA TOXIN TRANSLOCATION MECHANISMF32AI010394 · NIAID · UNIVERSITY OF COLORADO DENVER · PI TETER, KENNETH R · 1999 to 2001
$80k
NIAID NIH HHS F32 AI010394NIAID NIH HHS F32 AI10394NIAID NIH HHS K22 AI054568NIAID NIH HHS R01 AI031940NIAID NIH HHS R01 AI073783NIAID NIH HHS R01 AI31940
6 · The paper itself

Abstract

Cholera toxin (CT) moves from the cell surface to the endoplasmic reticulum (ER) by vesicular transport. In the ER, the catalytic CTA1 subunit dissociates from the holotoxin and enters the cytosol by exploiting the quality control system of ER-associated degradation (ERAD). It is hypothesized that CTA1 triggers its ERAD-mediated translocation into the cytosol by masquerading as a misfolded protein, but the process by which CTA1 activates the ERAD system remains unknown. Here, we directly assess the thermal stability of the isolated CTA1 polypeptide by biophysical and biochemical methods and correlate its temperature-dependent conformational state with susceptibility to degradation by the 20S proteasome. Measurements with circular dichroism and fluorescence spectroscopy demonstrated that CTA1 is a thermally unstable protein with a disordered tertiary structure and a disturbed secondary structure at 37 degrees C. A protease sensitivity assay likewise detected the temperature-induced loss of native CTA1 structure. This protease-sensitive conformation was not apparent when CTA1 remained covalently associated with the CTA2 subunit. Thermal instability in the dissociated CTA1 polypeptide could thus allow it to appear as a misfolded protein for ERAD-mediated export to the cytosol. In vitro, the disturbed conformation of CTA1 at 37 degrees C rendered it susceptible to ubiquitin-independent degradation by the core 20S proteasome. In vivo, CTA1 was also susceptible to degradation by a ubiquitin-independent proteasomal mechanism. ADP-ribosylation factor 6, a cytosolic eukaryotic protein that enhances the enzymatic activity of CTA1, stabilized the heat-labile conformation of CTA1 and protected it from in vitro degradation by the 20S proteasome. Thermal instability in the reduced CTA1 polypeptide has not been reported before, yet both the translocation and degradation of CTA1 may depend upon this physical property.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnimalsCHO CellsCholera ToxinCircular DichroismCricetinaeCricetulusEnzyme StabilityHot TemperatureProteasome Endopeptidase ComplexProtein BindingProtein ConformationProtein SubunitsSpectrometry, FluorescenceThermodynamicsADP-Ribosylation Factor 6ADP-Ribosylation FactorsCholera ToxinProteasome Endopeptidase ComplexProtein Subunits

Identifiers

PMID17976649
PMCPMC2175082
OpenAlexW2017841977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.